← Leaderboards
Prabir Ray
Yale University
$20,599,877
Attributed
$22,935,018
Total exposure
13
Grants
11
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.3M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$24,852,303 · 14
By mechanism
R01$14,131,576 · 6
P01$7,169,296 · 4
P50$2,331,585 · 1
R21$845,491 · 2
R56$374,355 · 1
Top collaborators
- Anuradha Ray10 shared
- Rama K Mallampalli1 shared
Others in their field
Top investigators on “Lung”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David Heimbrook · Leidos Biomedical Research, Inc.$372,040,227
- Chanza Baytop · Westat, Inc.$271,217,917
- Richard K. Wilson · Washington University$201,818,043
- Walter John Curran · Thomas Jefferson University$112,093,071
Research focus
LungCellsInflammationResponseProductionSignal TransductionLeadPlayMediatingCytokinePhenotypeIn VivoPathway InteractionsReportingChemokineLung InjuryCell TypeEpithelial CellsDendritic CellsAsthmaTranscription FactorPreventT-LymphocyteMouse Model
Grant awards (59)
Mechanisms of Antigen-Induced Tolerance in the Lung$528,200
R01 · FY2025 · AI
Training of Neutrophils to Defend Against a Lethal Bacterial Infection of the Lung$430,760
R21 · FY2025 · AI · contact PI
Mechanisms of Antigen-Induced Tolerance in the Lung$592,242
R01 · FY2024 · AI
Immunosuppression by Myeloid Cells in Pneumonia - Project 3$427,913
P01 · FY2023 · HL · contact PI
Immunosuppression by Myeloid Cells in Pneumonia - Project 3$427,833
P01 · FY2022 · HL · contact PI
Understanding Severe Asthma Using an Experimental Model$494,870
R01 · FY2021 · HL
Immunosuppression by Myeloid Cells in Pneumonia - Project 3$427,833
P01 · FY2021 · HL · contact PI
Understanding Severe Asthma Using an Experimental Model$494,870
R01 · FY2020 · HL
Immunosuppression by Myeloid Cells in Pneumonia - Project 3$427,913
P01 · FY2020 · HL · contact PI
Understanding Severe Asthma Using an Experimental Model$494,870
R01 · FY2019 · HL
Immunosuppression by Myeloid Cells in Pneumonia - Project 3$335,733
P01 · FY2019 · HL · contact PI
Cardiolipin as a Novel Mediator of Acute Lung Injury$1,917,285
P01 · FY2018 · HL · contact PI
Understanding Severe Asthma Using an Experimental Model$494,870
R01 · FY2018 · HL
Lung Epithelial-Immune Interactions In Respiratory Virus Infection$451,700
R01 · FY2018 · HL · contact PI
Dysregulation of Innate Immune response in Bacterial Pneumonia by Cardiolipin$402,669
P01 · FY2018 · HL · contact PI
Lung Epithelial-Immune Interactions In Respiratory Virus Infection$451,700
R01 · FY2017 · HL · contact PI
Dysregulation of Innate Immune response in Bacterial Pneumonia by Cardiolipin$408,148
P01 · FY2017 · HL · contact PI
Understanding Protective Immunoregulatory Mechanisms in the Infant Lung$599,572
R01 · FY2016 · AI · contact PI
Lung Epithelial-Immune Interactions In Respiratory Virus Infection$451,700
R01 · FY2016 · HL · contact PI
Dysregulation of Innate Immune response in Bacterial Pneumonia by Cardiolipin$403,987
P01 · FY2016 · HL · contact PI
Understanding Severe Asthma Using an Experimental Model$384,933
R01 · FY2016 · HL
Understanding Protective Immunoregulatory Mechanisms in the Infant Lung$733,700
R01 · FY2015 · AI · contact PI
Lung Epithelial-Immune Interactions In Respiratory Virus Infection$451,700
R01 · FY2015 · HL · contact PI
Dysregulation of Innate Immune response in Bacterial Pneumonia by Cardiolipin$416,211
P01 · FY2015 · HL · contact PI
Understanding Severe Asthma Using an Experimental Model$387,597
R01 · FY2015 · HL
Understanding Protective Immunoregulatory Mechanisms in the Infant Lung$430,575
R01 · FY2014 · AI · contact PI
Dysregulation of Innate Immune response in Bacterial Pneumonia by Cardiolipin$406,160
P01 · FY2014 · HL · contact PI
Understanding Severe Asthma Using an Experimental Model$391,685
R01 · FY2014 · HL
Understanding Protective Immunoregulatory Mechanisms in the Infant Lung$430,414
R01 · FY2013 · AI · contact PI
Understanding Severe Asthma Using an Experimental Model$406,146
R01 · FY2013 · HL
Understanding Protective Immunoregulatory Mechanisms in the Infant Lung$447,568
R01 · FY2012 · AI · contact PI
Viral Infection and Impairment of Immune Tolerance$374,355
R56 · FY2012 · AI · contact PI
Targeting c-kit in Dendritic Cells to Control allergic Immune Responses$187,481
R21 · FY2011 · AI · contact PI
KGF and Inhibition of Pulmonary Fibrosis$516,024
P50 · FY2010 · HL · contact PI
Targeting c-kit in Dendritic Cells to Control allergic Immune Responses$227,250
R21 · FY2010 · AI · contact PI
KGF and Inhibition of Pulmonary Fibrosis$501,914
P50 · FY2009 · HL · contact PI
KGF and Protection from Hyperoxic Lung Injury$353,420
R01 · FY2009 · HL · contact PI
KGF and Inhibition of Pulmonary Fibrosis$471,505
P50 · FY2008 · HL · contact PI
KGF and Protection from Hyperoxic Lung Injury$353,420
R01 · FY2008 · HL · contact PI
Chemokines and Immune Regulation in the Lung$310,154
R01 · FY2008 · HL · contact PI
KGF and Inhibition of Pulmonary Fibrosis$422,893
P50 · FY2007 · HL · contact PI
KGF and Protection from Hyperoxic Lung Injury$353,420
R01 · FY2007 · HL · contact PI
Chemokines and Immune Regulation in the Lung$310,347
R01 · FY2007 · HL · contact PI
KERATINOCYTE GROWTH FACTOR$306,316
P01 · FY2007 · HL · contact PI
KGF and Inhibition of Pulmonary Fibrosis$419,249
P50 · FY2006 · HL · contact PI
KGF and Protection from Hyperoxic Lung Injury$363,975
R01 · FY2006 · HL · contact PI
Chemokines and Immune Regulation in the Lung$319,811
R01 · FY2006 · HL · contact PI
KERATINOCYTE GROWTH FACTOR$295,626
P01 · FY2006 · HL · contact PI
Chemokines and Immune Regulation in the Lung$327,699
R01 · FY2005 · HL
KERATINOCYTE GROWTH FACTOR$287,013
P01 · FY2005 · HL
Chemokines and Immune Regulation in the Lung$328,505
R01 · FY2004 · HL
KGF and Protection from Hyperoxic Lung Injury$320,876
R01 · FY2004 · HL
KERATINOCYTE GROWTH FACTOR$278,656
P01 · FY2004 · HL
KGF and Protection from Hyperoxic Lung Injury$322,254
R01 · FY2003 · HL
KGF and Protection from Hyperoxic Lung Injury$323,629
R01 · FY2002 · HL
KGF and Protection from Hyperoxic Lung Injury$350,000
R01 · FY2001 · HL
DIFFERENTIAL CHEMOKINE GENE EXPRESSION IN THE LUNG$255,551
R01 · FY2001 · HL
DIFFERENTIAL CHEMOKINE GENE EXPRESSION IN THE LUNG$85,239
R01 · FY2001 · HL
DIFFERENTIAL CHEMOKINE GENE EXPRESSION IN THE LUNG$334,364
R01 · FY2000 · HL